Key Insights

Highlights

Success Rate

85% trial completion

Published Results

101 trials with published results (12%)

Research Maturity

371 completed trials (45% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

8.0%

66 terminated out of 829 trials

Success Rate

84.9%

-1.7% vs benchmark

Late-Stage Pipeline

7%

61 trials in Phase 3/4

Results Transparency

27%

101 of 371 completed with results

Key Signals

101 with results85% success66 terminated

Data Visualizations

Phase Distribution

603Total
Not Applicable (295)
Early P 1 (6)
P 1 (123)
P 2 (118)
P 3 (47)
P 4 (14)

Trial Status

Completed371
Unknown146
Recruiting116
Terminated66
Active Not Recruiting47
Not Yet Recruiting41

Trial Success Rate

84.9%

Benchmark: 86.6%

Based on 371 completed trials

Clinical Trials (829)

Showing 20 of 20 trials
NCT07059884Not ApplicableRecruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

NCT04703829Not ApplicableActive Not RecruitingPrimary

Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy

NCT05868226Phase 1Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT07850778Completed

ONS USE IN COLON CANCER

NCT07127874Phase 1RecruitingPrimary

A Study of PHN-012 in Patients With Advanced Solid Tumors

NCT02595957RecruitingPrimary

Genomic Services Research Program

NCT03623464Not ApplicableSuspended

RCT of Mobile Apps & FitBit v. Usual Care

NCT00034216Recruiting

Collection of Blood From Patients With Cancer

NCT07841236Phase 2RecruitingPrimary

ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer

NCT03702309Recruiting

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

NCT07840677Phase 2RecruitingPrimary

Tafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer

NCT05513742Phase 2Completed

A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer

NCT02293954Not ApplicableActive Not Recruiting

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

NCT04708470Phase 1Completed

A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers

NCT04512209Not ApplicableCompleted

Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT07705334Phase 1Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

NCT04517708Not ApplicableCompleted

Effectiveness of Nutritional Interventions for Cancer Patients Undergoing Chemotherapy

NCT07825766Active Not RecruitingPrimary

The Role of Total Abdominal Autonomic Nerve Preservation During the Resection of Right/Left Colon Cancer: Prospective Clinical Trial

NCT03667612Completed

Endogenous Mechanisms of Inactivation of the Endothelium Tumor

Scroll to load more

Research Network

Activity Timeline